Bupivacaine sustained-release - MedinCell
Latest Information Update: 12 Aug 2016
Price : $50
At a glance
- Originator MedinCell S.A.
- Class Anilides; Local anaesthetics; Non-opioid analgesics; Pipecolic acids; Small molecules
- Mechanism of Action Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Postoperative pain
Most Recent Events
- 12 Aug 2016 Chemical structure information added